Samuel Fenn
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 5
-
- Antimicrobial Resistance in Staphylococcus 2
- Tuberculosis Research and Epidemiology 1
- Co-authors
- Kim R. Hardie (2 shared papers)Zhiyong Zong (1 shared paper)Simon J. Foster (2 shared papers)Robert D. Turner (2 shared papers)Christopher Connor (1 shared paper)Yu Feng (1 shared paper)Alan McNally (1 shared paper)Fabian Grein (1 shared paper)
- Journals
- Journal of Medical Microbiology (2 papers)eLife (1 paper)mBio (1 paper)Matter (1 paper)Journal of Antimicrobial Chemotherapy (1 paper)
- Partner nations
- United KingdomSwitzerlandIreland
In The Last Decade
Samuel Fenn
8 papers receiving 278 citations
Peers
Comparison fields: 5 of 70
- Molecular Medicine 106
- Applied Microbiology and Biotechnology 18
- Endocrinology 34
- Infectious Diseases 75
- Clinical Biochemistry 25
Countries citing papers authored by Samuel Fenn
This map shows the geographic impact of Samuel Fenn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Fenn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Fenn more than expected).
Fields of papers citing papers by Samuel Fenn
This network shows the impact of papers produced by Samuel Fenn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Fenn. The network helps show where Samuel Fenn may publish in the future.
Co-authors
The 25 scholars most cited alongside Samuel Fenn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 75 | |
| 2 | 2018 | 63 | |
| 3 | 2016 | 51 | |
| 4 | 2018 | 45 | |
| 5 | 2022 | 18 | |
| 6 | 2023 | 14 | |
| 7 | 2021 | 11 | |
| 8 | 2024 | 3 |
About Samuel Fenn
Samuel Fenn is a scholar working on Molecular Medicine, Infectious Diseases, Molecular Biology, Epidemiology and Pharmacology, having authored 8 papers that have together received 280 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (5 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Bacterial biofilms and quorum sensing (2 papers), Antibiotics Pharmacokinetics and Efficacy (1 paper), Urinary Tract Infections Management (1 paper), Tuberculosis Research and Epidemiology (1 paper), Biochemical and Structural Characterization (1 paper) and 3D Printing in Biomedical Research (1 paper). The work is most often cited by research in Molecular Medicine (106 citations), Applied Microbiology and Biotechnology (18 citations), Endocrinology (34 citations), Infectious Diseases (75 citations) and Clinical Biochemistry (25 citations). Samuel Fenn has collaborated with scholars based in United Kingdom, Switzerland and Ireland. Frequent co-authors include Kim R. Hardie, Zhiyong Zong, Simon J. Foster, Robert D. Turner, Christopher Connor, Yu Feng, Alan McNally, Fabian Grein, Stéphane Mesnage and Nicolas Olivier. Their work appears in journals such as Journal of Medical Microbiology, eLife, mBio, Matter and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.